Article
Telaprevir-induced DRESS.
Journal of drugs in dermatology : JDD - 1 Feb 2014
Kesar Vivek, Kesar Varun, Khaitova Viktoriya, Motamed David, Schiano Thomas
Abstract excerpt
Telaprevir, a protease inhibitor, was recently approved for management of Chronic Hepatits C (CHC) due to HCV genotype 1. Various RCTs have demonstarted increased incidence of cutaneous adverse effects with use of Telaprevir. Herein, we report two cases of drug rash with eosinophilia and systemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
